Cellectar Biosciences Inc
CLRB
|
|
| |
|
| Trading Volume | 16,383 |
|
|
4.24 - 1.77 |
| Market Cap Full | $ 27M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 16.2% | 43.3% | -15.8% | 11.5% |
| Q2 | - | -40.5% | 35.4% | -46% |
| Q3 | - | 2.8% | 35.4% | 740% |
| Q4 | - | -86.1% | -3.2% | -49.1% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.2 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 41.2 | 0.3 | 1.3 | -23.9 | 2.2 | -24.2 | -8.6 | 2.8 | - | - | - | -80.7 |
| 2023 | |||||||||||
| -11.1 | 2.6 | -7.7 | 6.3 | 2 | 25 | - | -9.2 | 49.2 | -8.3 | 2.1 | 12.2 |
| 2022 | |||||||||||
| -9.6 | -15 | 45.1 | -27 | -24.1 | -2.4 | 889.5 | 38.5 | -38.7 | -39.9 | -6.9 | -9 |
| 2021 | |||||||||||
| -7.3 | -2.6 | -13.4 | -1.9 | 2.2 | -26.3 | -8.4 | -6.4 | -9.3 | -6.2 | -20.4 | -3.9 |
| 2020 | |||||||||||
| 19.9 | -22.5 | -36.5 | 28 | -11.3 | -15.4 | 18 | -21.2 | 3.4 | -7.3 | 10.5 | 63.5 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.8 | -1 | -0.1 | -0.4 |
| Q2 | -0.7 | -1.2 | -0.1 | -0.3 |
| Q3 | -1.2 | -1.3 | -0.1 | -0.2 |
| Q4 | 0 | -0.6 | -0.9 | 0.1 |
| A | -2.7 | -4.1 | -4.4 | -1.8 |